Cancer Genome Atlas Network (2015) Genomic classification of cutaneous melanoma. Cell 161(7):1681–1696. https://doi.org/10.1016/j.cell.2015.05.044

Article  CAS  Google Scholar 

Elder D, Barnhill R, Bastian B (2018) Melanocytic tumour classification and the pathway concept of melanoma pathogenesis. In: Elder D, Massi D, Scolyer R, Willemze R (eds) WHO Classification of Skin Tumours, Vol. 11, 4th edn. IARC, Lyon, pp 66–71

Hayward NK, Wilmott JS, Waddell N et al (2017) Whole-genome landscapes of major melanoma subtypes. Nature 545(7653):175–180. https://doi.org/10.1038/nature22071

Article  PubMed  CAS  Google Scholar 

National Comprehensive Cancer Network (2024) Melanoma; Cutaneous, Version 2, NCCN clinical practice guidelines in oncology. Available from: https://www.nccn.org/home. Accessed May 2024

Fukushima S, Miyashita A, Kimura T et al (2024) Deciphering the role of adjuvant therapy in melanoma and its actual benefits. J Dermatol 51(3):335–342. https://doi.org/10.1111/1346-8138.17093

Article  PubMed  Google Scholar 

Nakamura Y, Asai J, Igaki H et al (2020) Japanese dermatological association guidelines: outlines of guidelines for cutaneous melanoma 2019. J Dermatol 47(2):89–103. https://doi.org/10.1111/1346-8138.15151

Article  PubMed  Google Scholar 

Bai X, Shoushtari AN, Betof Warner A et al (2022) Benefit and toxicity of programmed death-1 blockade vary by ethnicity in patients with advanced melanoma: an international multicentre observational study. Br J Dermatol 187(3):401–410. https://doi.org/10.1111/bjd.21241

Article  PubMed  CAS  Google Scholar 

Wolchok JD, Chiarion-Sileni V, Gonzalez R et al (2017) Overall survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med 377(14):1345–1356. https://doi.org/10.1056/NEJMoa1709684

Article  PubMed  PubMed Central  CAS  Google Scholar 

Nakamura Y, Namikawa K, Kiniwa Y et al (2022) Efficacy comparison between anti-PD-1 antibody monotherapy and anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy for advanced acral melanoma: a retrospective, multicenter study of 254 Japanese patients. Eur J Cancer 176:78–87. https://doi.org/10.1016/j.ejca.2022.08.030

Article  PubMed  CAS  Google Scholar 

Takahashi A, Namikawa K, Ogata D et al (2023) Updated analysis of nivolumab and ipilimumab combination therapy in Japanese patients with advanced melanoma. J Dermatol 50(4):525–535. https://doi.org/10.1111/1346-8138.16669

Article  PubMed  CAS  Google Scholar 

Sakaizawa K, Ashida A, Uchiyama A et al (2015) Clinical characteristics associated with BRAF, NRAS and KIT mutations in Japanese melanoma patients. J Dermatol Sci 80(1):33–37. https://doi.org/10.1016/j.jdermsci.2015.07.012

Article  PubMed  CAS  Google Scholar 

Inozume T, Namikawa K, Kato H et al (2023) Analyzing the relationship between the efficacy of first-line immune checkpoint inhibitors and cumulative sun damage in Japanese patients with advanced BRAF wild-type nonacral cutaneous melanoma: a retrospective real-world, multicenter study. J Dermatol Sci 110(1):19–26. https://doi.org/10.1016/j.jdermsci.2023.03.008

Article  PubMed  CAS  Google Scholar 

Michielin O, van Akkooi ACJ, Ascierto PA et al (2019) Cutaneous melanoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 30(12):1884–1901. https://doi.org/10.1093/annonc/mdz411

Article  PubMed  CAS  Google Scholar 

Kohno T, Kato M, Kohsaka S et al (2022) C-CAT: the national datacenter for cancer genomic medicine in Japan. Cancer Discov 12(11):2509–2515. https://doi.org/10.1158/2159-8290.CD-22-0417

Article  PubMed  PubMed Central  Google Scholar 

Frampton GM, Fichtenholtz A, Otto GA et al (2013) Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat Biotechnol 31(11):1023–1031. https://doi.org/10.1038/nbt.2696

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gao J, Aksoy BA, Dogrusoz U et al (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. https://doi.org/10.1126/scisignal.2004088

Article  PubMed  PubMed Central  Google Scholar 

Newell F, Kong Y, Wilmott JS et al (2019) Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets. Nat Commun 10(1):3163. https://doi.org/10.1038/s41467-019-11107-x

Article  PubMed  PubMed Central  CAS  Google Scholar 

Newell F, Wilmott JS, Johansson PA et al (2020) Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity. Nat Commun 11(1):5259. https://doi.org/10.1038/s41467-020-18988-3

Article  PubMed  PubMed Central  CAS  Google Scholar 

Broit N, Johansson PA, Rodgers CB et al (2021) Meta-analysis and systematic review of the genomics of mucosal melanoma. Mol Cancer Res 19(6):991–1004. https://doi.org/10.1158/1541-7786.MCR-20-0839

Article  PubMed  CAS  Google Scholar 

Broit N, Johansson PA, Rodgers CB et al (2022) Systematic review and meta-analysis of genomic alterations in acral melanoma. Pigment Cell Melanoma Res 35(3):369–386. https://doi.org/10.1111/pcmr.13034

Article  PubMed  PubMed Central  CAS  Google Scholar 

Suehnholz SP, Nissan MH, Zhang H et al (2024) Quantifying the expanding landscape of clinical actionability for patients with cancer. Cancer Discov 14(1):49–65. https://doi.org/10.1158/2159-8290.CD-23-0467

Article  PubMed  CAS  Google Scholar 

Zou Z, Ou Q, Ren Y et al (2020) Distinct genomic traits of acral and mucosal melanomas revealed by targeted mutational profiling. Pigment Cell Melanoma Res 33(4):601–611. https://doi.org/10.1111/pcmr.12865

Article  PubMed  CAS  Google Scholar 

Huang F, Li J, Wen X et al (2022) Next-generation sequencing in advanced Chinese melanoma reveals therapeutic targets and prognostic biomarkers for immunotherapy. Sci Rep 12(1):9559. https://doi.org/10.1038/s41598-022-13391-y

Article  PubMed  PubMed Central  CAS  Google Scholar 

Farshidfar F, Rhrissorrakrai K, Levovitz C et al (2022) Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis. Nat Commun 13(1):898. https://doi.org/10.1038/s41467-022-28566-4

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yeh I, Jorgenson E, Shen L et al (2019) Targeted genomic profiling of acral melanoma. J Natl Cancer Inst 111(10):1068–1077. https://doi.org/10.1093/jnci/djz005

Article  PubMed  PubMed Central  CAS  Google Scholar 

Moon KR, Choi YD, Kim JM et al (2018) Genetic alterations in primary acral melanoma and acral melanocytic nevus in Korea: common mutated genes show distinct cytomorphological features. J Invest Dermatol 138(4):933–945. https://doi.org/10.1016/j.jid.2017.11.017

Article  PubMed  CAS  Google Scholar 

Indini A, Roila F, Grossi F et al (2021) Molecular profiling and novel therapeutic strategies for mucosal melanoma: a comprehensive review. Int J Mol Sci 23(1):147. https://doi.org/10.3390/ijms23010147

Article  PubMed  PubMed Central  CAS  Google Scholar 

Coupland S, Folberg R, Kivela T et al (2018) Ocular melanocytic tumours, Uveal melanoma. In: Elder D, Massi D, Scolyer R, Willemze R (eds) WHO Classification of Skin Tumours, Vol. 11, 4th edn. IARC, Lyon, pp137–138

Karlsson J, Nilsson LM, Mitra S et al (2020) Molecular profiling of driver events in metastatic uveal melanoma. Nat Commun 11(1):1894. https://doi.org/10.1038/s41467-020-15606-0

Article  PubMed  PubMed Central  CAS